SignatureFD
ARQT icon

SignatureFD’s Arcutis Biotherapeutics ARQT Stock Holding History

SignatureFD’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.5K Hold
2,137
– – ﹤0.01% 1885
2026
Q2 		$56K Sell
2,137
-10
-0.5% -$233 ﹤0.01% 1802
2026
Q1 		$50.6K Hold
2,147
– – ﹤0.01% 1710
2025
Q4 		$62.3K Buy
2,147
+10
+0.5% +$256 ﹤0.01% 1525
2025
Q3 		$40.3K Hold
2,137
– – ﹤0.01% 1754
2025
Q2 		$30K Sell
2,137
-1,413
-40% -$19.8K ﹤0.01% 1873
2025
Q1 		$55.5K Buy
3,550
+55
+2% +$775 ﹤0.01% 1508
2024
Q4 		$48.7K Hold
3,495
– – ﹤0.01% 1602
2024
Q3 		$32.5K Hold
3,495
– – ﹤0.01% 1819
2024
Q2 		$32.5K Sell
3,495
-24
-0.7% -$217 ﹤0.01% 1733
2024
Q1 		$34.9K Buy
+3,519
New +$26.3K ﹤0.01% 1730
2023
Q4 		– Sell
-346
Closed -$1.84K – 3133
2023
Q3 		$1.84K Sell
346
-22
-6% -$187 ﹤0.01% 2793
2023
Q2 		$3.51K Buy
368
+250
+212% +$2.78K ﹤0.01% 2634
2023
Q1 		$1.3K Sell
118
-174
-60% -$2.52K ﹤0.01% 2924
2022
Q4 		$4.32K Sell
292
-44
-13% -$769 ﹤0.01% 2538
2022
Q3 		$6K Sell
336
-49
-13% -$1.11K ﹤0.01% 2309
2022
Q2 		$8K Buy
385
+93
+32% +$1.91K ﹤0.01% 2205
2022
Q1 		$6K Buy
292
+282
+2,820% +$4.77K ﹤0.01% 2379
2021
Q4 		$0 Sell
10
-585
-98% -$11.6K ﹤0.01% 3098
2021
Q3 		$14K Buy
+595
New +$13.6K ﹤0.01% 1897

Other funds holding ARQT

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

SignatureFD's ARQT Position: Q3 2026 in Review

SignatureFD held its Arcutis Biotherapeutics (ARQT) position steady in Q3 2026 at 2,137 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

SignatureFD first reported a position in ARQT in Q3 2021 and has held it in 20 quarters since. The position peaked at $62.3K in Q4 2025. 176 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • SignatureFD held 2,137 shares of Arcutis Biotherapeutics worth $56.5K as of Q3 2026.
  • SignatureFD left its Arcutis Biotherapeutics share count unchanged in Q3 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1885 holding.
  • SignatureFD first reported a position in Arcutis Biotherapeutics in Q3 2021 and has held it in 20 quarters since.
  • SignatureFD's Arcutis Biotherapeutics position peaked at $62.3K in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.